Back to search results

External Facilitation to Increase Prescribing of AUD Medications

This study is testing a program called "Implementation Facilitation" to help doctors in psychiatric clinics prescribe more medications for Alcohol Use Disorder (AUD). This program involves an expert working with clinic staff to provide education, training on screening for AUD, and support for reviewing how well medications are being prescribed. You could be eligible if you are a prescriber, clinician, or administrator at one of the three participating clinics, or a patient aged 18 to 90 with a major mental illness (like depression, bipolar disorder, or schizophrenia) and Alcohol Use Disorder. The main goal is to see if this program increases the prescribing of AUD medications six months after the program ends. The study aims to enroll 40 participants, but its current status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 40 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study measures the prescribing of medications for alcohol use disorder at 6 months after the end of the implementation facilitation program.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07053098

External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting

Recruiting
NAAges 18–90InterventionalHealth services
University of Maryland, Baltimore
~40 participants
Updated 2026-06-03 on ClinicalTrials.gov
What's tested:Implementation Facilitation

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Prescribing medications for alcohol use disorder
Measured over 6 months after the end of implementation facilitation

Conditions

Alcohol-Related Disorders
Psychiatric Disorder

Explore related trials

Alcohol use disorderBipolar DisorderPost-Traumatic Stress DisorderPsychosisSchizophreniaUnipolar Depression

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Melanie Bennett · PRINCIPAL_INVESTIGATOR · University of Maryland, Baltimore

Who to contact

Melanie Bennett, PhD
[email protected]
410-706-2490
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics.
For patients: has major mental illness (major depressive disorders, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders; posttraumatic stress disorder)
For patients: has Alcohol Use Disorder and is being treated in one of the three participating clinics.

Exclusion

For all: age is less than 18 years old
For all: not able to complete informed consent

What this trial measures

  • Prescribing medications for alcohol use disorder6 months after the end of implementation facilitation

    Change in the proportion of eligible patients prescribed a medication for alcohol use disorder in the clinic